Home  >  Products  >  HGSNAT (heparan-alpha-glucosaminide N-acetyltransferase ) Blocking Peptide (the C terminal of HGSNAT)(100ug)
HGSNAT (heparan-alpha-glucosaminide N-acetyltransferase ) Blocking Peptide (the C terminal of HGSNAT)(100ug)

HGSNAT (heparan-alpha-glucosaminide N-acetyltransferase ) Blocking Peptide (the C terminal of HGSNAT)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-HGSNAT Antibody (ARP65767_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP65767
Size: 100ug
Weight: 2kDa
Gene: 138050
Format: Lyophilized powder
Target: This gene encodes a lysosomal acetyltransferase, which is one of several enzymes involved in the lysosomal degradation of heparin sulfate. Mutations in this gene are associated with Sanfilippo syndrome C, one type of the lysosomal storage disease mucopolysaccaridosis III, which results from impaired degradation of heparan sulfate.
Alternative names: DKFZp686G24175; FLJ22242; FLJ32731; HGNAT; MPS3C; TMEM76